It is the third such deal this year - it has already sold former Shire dry eye drug Xiidra to Novartis for up to $5.3 billion, and sold its fibrin sealant patch Tachosil to Ethicon for around $400 ...

In the presence of ten or more lesions, the disease is considered generalized GA. Evidence regarding treatment is scarce, with a notable limitation that most studies are case series involving a small ...